307 results on '"Margarit, Immaculada"'
Search Results
2. Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles
3. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study
4. Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles
5. Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
6. Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes
7. Impact of Protein Nanoparticle Shape on the Immunogenicity of Antimicrobial Glycoconjugate Vaccines
8. A Multidisciplinary Structural Approach to the Identification of the Haemophilus influenzae Type b Capsular Polysaccharide Protective Epitope.
9. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women
10. Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide
11. A Multidisciplinary Structural Approach to the Identification of the Haemophilus influenzaeType b Capsular Polysaccharide Protective Epitope
12. Complete Genome Sequence and Comparative Genomic Analysis of an Emerging Human Pathogen, Serotype V Streptococcus agalactiae
13. Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
14. Publisher Correction: Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon
15. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera
16. The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles
17. Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates
18. Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
19. FHUSPA2/10 is a bactericidal monoclonal antibody targeting multiple repeated sequences of Moraxella catarrhalis UspA2
20. Structure of the Type IX Group B Streptococcus Capsular Polysaccharide and Its Evolutionary Relationship with Types V and VII
21. Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice
22. Immune responses to invasive group B streptococcal disease in adults
23. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study
24. Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case
25. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus
26. Preventing Bacterial Infections with Pilus-Based Vaccines: The Group B Streptococcus Paradigm
27. Sequence Variation in Group A Streptococcus Pili and Association of Pilus Backbone Types with Lancefield T Serotypes
28. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci
29. Use of Lactococcus lactis Expressing Pili from Group B Streptococcus as a Broad-Coverage Vaccine against Streptococcal Disease
30. Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate
31. Dissecting the Human Response to Staphylococcus aureus Systemic Infections
32. Surfome Analysis as a Fast Track to Vaccine Discovery: IDENTIFICATION OF A NOVEL PROTECTIVE ANTIGEN FOR GROUP B STREPTOCOCCUS HYPERVIRULENT STRAIN COH1
33. Microbial Genomics: Targeted Antimicrobial Therapy and Genome Vaccines
34. Conserved anchorless surface proteins as group A streptococcal vaccine candidates
35. Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating and immune activation in rostral diencephalon
36. Pili in Gram-positive pathogens
37. Anti-dopamine D2 receptor antibodies in chronic tic disorders
38. Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort
39. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial
40. Front Cover: Structure‐Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine (Chem. Eur. J. 31/2020)
41. Structure‐Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine
42. Typing of the pilus-protein-encoding FCT region and biofilm formation as novel parameters in epidemiological investigations of Streptococcus pyogenes isolates from various infection sites
43. Scavenger receptor gp340 aggregates group A streptococci by binding pili
44. Sequence variation in group A Streptococcus pili and association of pilus backbone types and Lancefield T serotypes
45. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation
46. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae
47. Genome Analysis Reveals Pili in Group B Streptococcus
48. European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents
49. Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort
50. Novel Multiplex Immunoassays for Quantification of IgG against Group B Streptococcus Capsular Polysaccharides in Human Sera
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.